B
Bicara Therapeutics Inc
NASDAQ:BCAX
Bicara Therapeutics Inc
NASDAQ:BCAX
Price:
15.1
USD
-7.76%
Market Closed
Market Cap:
$827.2m
Cash Flow Statement
Cash Flow Statement
Bicara Therapeutics Inc
Bicara Therapeutics Inc
Currency: USD
| Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||
| Net Income |
(82)
|
(68)
|
(105)
|
(103)
|
(122)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
|
| Stock-Based Compensation |
4
|
7
|
11
|
14
|
16
|
|
| Other Non-Cash Items |
20
|
7
|
11
|
12
|
14
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
(1)
|
(14)
|
(9)
|
(11)
|
(6)
|
|
| Cash from Operating Activities |
(63)
N/A
|
(75)
-18%
|
(103)
-38%
|
(101)
+2%
|
(113)
-12%
|
|
| Investing Cash Flow | ||||||
| Capital Expenditures |
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Items |
0
|
0
|
0
|
0
|
(236)
|
|
| Cash from Investing Activities |
(1)
N/A
|
(0)
+98%
|
(0)
N/A
|
(0)
-433%
|
(236)
-491 902%
|
|
| Financing Cash Flow | ||||||
| Net Issuance of Common Stock |
570
|
334
|
334
|
333
|
0
|
|
| Other |
0
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
570
N/A
|
334
-41%
|
334
+0%
|
334
0%
|
0
-100%
|
|
| Change in Cash | ||||||
| Net Change in Cash |
506
N/A
|
259
-49%
|
232
-11%
|
233
+0%
|
(349)
N/A
|
|
| Free Cash Flow | ||||||
| Free Cash Flow |
(64)
N/A
|
(75)
-17%
|
(103)
-38%
|
(101)
+2%
|
(113)
-12%
|
|
Switch to:
Switch to:
See Also
Discover More
